论文部分内容阅读
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death and the first cause of death in patients with cirrhosis. An increasing incidence worldwide and poor prognosis are reported despite the application of screening protocols and potentially radical therapies (1).